# TALTZ

NDC: 0002-7724
Generic name: ixekizumab
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20160322

FDA application: BLA125521

## Active ingredients

- IXEKIZUMAB: 80 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-7724"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-7724
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac96658a-d7dc-4c7c-8928-2adcdf4318b2